For example, semaglutide dosing differs substantially between Ozempic (diabetes) and Wegovy (weight management)
A randomized trial comparing dose reduction, temporary discontinuation, and symptomatic treatment would be valuable but has not been conducted
It also gives you a chance to briefly mention your related article on Tirzepatide vs Semaglutide, though the main focus here is on what comes after tirzepatide, not what came before
This is the same model used by MEDVi, Hims, Ro, and most telehealth GLP-1 providers
This collaborative approach ensures that the decision-making process is informed by both medical expertise and the unique circumstances of each pregnancy
Expect a gradual trend, especially as doses are increased slowly to improve tolerability